Pharmaceutical Industry

Mundipharma LATAM GmbH 

Basel · Since 2015

Mundipharma LATAM GmbH is a global healthcare company focused on the development and commercialisation of medicines in specialty therapeutic areas, including cancer pain management, oncology, biosimilars and anti‑infectives. It provides medical products and engages with healthcare professionals and partners to support patient‑centred care.

Mundipharma Near East GmbH 

Basel · Since 2014

Mundipharma Near East GmbH develops and markets pharmaceutical products with a focus on cancer pain management and other specialty care therapeutic areas.

Mundipharma MEA GmbH 

Basel · Since 2013

Mundipharma MEA GmbH is a pharmaceutical company that markets medicines and healthcare products and provides medical information. The company operates pharmacovigilance reporting for side effects and maintains contact channels for media and careers; the website references products such as Betadina and Hedrin.

MV BioTherapeutics SA 

Bellinzona · Since 2018

The core activity of MV BioTherapeutics SA is the development and application of technologies for regulating the intestinal ecosystem in medical applications, particularly through the ApyraMed/ApyraVax platform. This platform enables the conditional regulation of the intestinal ecosystem to control the adaptive immune response and promote mutualism with intestinal commensals. The company focuses on developing solutions for medical applications, particularly in the fields of mucosal immunology and biomedicine.

mybacs AG 

Zug · Since 2018

The company mybacs develops and distributes products based on the latest scientific findings in the field of microbiome health, particularly probiotics and dietary supplements that aim to promote gut health and overall well-being.

Myria Biosciences AG 

Basel · Since 2022

The core activity of Myria Biosciences is the development of therapeutics based on microorganisms (synthetic biology) using artificial intelligence (AI) and high-performance analytics. The company aims to discover and develop new medicines for unmet medical needs.

Mysthera Therapeutics AG 

Basel · Since 2023

NANONICA SA 

Lugano · Since 2006

NANONICA SA is a firm focused on knowledge transfer and commercialization of academic research in nanotechnology and microtechnology. It provides advisory services to identify projects and expertise, and supports development and market introduction of technologies across medicine, energy and environmental science.

NatSwissMed SA 

Chénens · Since 2023

NATULYS Sàrl 

Epalinges · Since 2006

NATULYS Sàrl is a laboratory focused on phytotherapy that produces natural products for joint, muscle, bone and tendon health. Offerings include Silorga (a liquid organic silicon solution), Silconfort (a silicon gel) and supplements containing glucosamine, chondroitin sulfate, harpagophytum and turmeric, distributed in Switzerland and Europe via distributors and online.

NBE-Therapeutics AG 

Basel · Since 2012

The core activity of NBE-Therapeutics AG is the development and research of therapeutics, particularly in the field of cancer treatment. The company focuses on the development of antibody-drug conjugates (ADCs) and other therapeutics targeting the fight against cancer cells.

NBP-Production AG 

Zollikon · Since 2020

NBP-Production AG manufactures and distributes natural-based products and provides contract filling services. Its portfolio includes natural cosmetics, disinfectants and Schungit products for sectors such as healthcare, agriculture, industry, tourism/food service and beauty.

Nemosia AG 

Winterthur · Since 2022

The core activity of Nemosia is the development of solutions to combat neurodegenerative diseases, particularly through the development of radiopharmaceuticals and the application of Positron Emission Tomography (PET) for the diagnosis and treatment of brain disorders.

Neovii Pharmaceuticals AG 

Jona · Since 2013

Neovii Pharmaceuticals AG is an independent global biopharmaceutical company that develops and brings to market polyclonal antibody immunosuppressive therapies. Its research and products focus on transplantation medicine, stem cell transplantation, and hematology/oncology and immune disorders; the product range includes Grafalon®.

Bioviida Ventures GmbH 

Jona · Since 2019

Neovii Biopharmaceuticals GmbH is a biopharmaceutical company that develops and markets polyclonal antibody therapies for transplantation medicine and hematology/oncology. The company supports research in solid-organ and stem-cell transplantation, immune disorders and hemato-oncological conditions, and its portfolio includes the polyclonal antibody product Grafalon®.

Neurocrine Switzerland GmbH 

Allschwil · Since 2023

Neurocrine Switzerland GmbH conducts research and development of treatments for neurological, neuroendocrine and neuropsychiatric disorders. The organisation’s portfolio includes approved medicines for conditions such as tardive dyskinesia, chorea associated with Huntington’s disease, congenital adrenal hyperplasia, endometriosis and uterine fibroids, and it maintains a pipeline with compounds in mid‑to‑late stage clinical development.

NOBEL Pharma Schweiz AG 

Rotkreuz · Since 2018

The core activity of NOBEL Pharma Schweiz AG is the development, manufacture and marketing of pharmaceutical products, in particular generics and OTC products, which are used in various therapeutic areas such as allergy, flu/cold, cardiovascular, gastrointestinal, nervous system, pain/inflammation, metabolism and urogenital tract.

Noema Pharma AG 

Basel · Since 2020

The core activity of Noema Pharma is the development and marketing of therapeutics for central nervous system (CNS) disorders. The company focuses on developing treatments for rare and severe brain and nervous system diseases, such as Tuberous Sclerosis, Trigeminal Neuralgia, Tourette's Syndrome, and Menopause symptoms.

Nonex GmbH 

Bern · Since 2024

Nonex GmbH develops biodegradable technologies and products for applications in food, cosmetics, healthcare, cleaning, and packaging. Its offerings include nano-fiber-based drug delivery systems, edible biopolymer food products, biodegradable gels for beauty and cleaning, and services such as project management, consulting and research communication for bio- and medical-technology projects.

Noorik Biopharmaceuticals AG 

Basel · Since 2010

Noorik Biopharmaceuticals AG is a privately owned drug development company focused on repurposing existing drugs and conducting research and development. It is developing a micro-dose formulation of ambrisentan, an endothelin receptor antagonist, for indications including severe COVID-19 pneumonia, portal hypertension and pulmonary arterial hypertension, and has developed novel oral and parenteral formulations, holds second medical use patents and is seeking co-development partners.